⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 10, 2025

Aldactone 200 mg/ 10 ml Injektionslösung 200 mg/ 10 ml (Injektionslösung)

📷 EU Safety Watch placeholder
Aldactone 200 mg/ 10 ml Injektionslösung 200 mg/ 10 ml (Injektionslösung)
📷 EU Safety Watch placeholder
Parallel export ban in effect. Supply delayed due to manufacturing issues.
🗄
Archived (older alert)
This alert was reported 522 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
119 days in total
May 18, 2026 September 14, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Aldactone is a liquid medicine given by injection. It contains a substance called canrenoic acid.

What's happening? There is a short supply of this injection. It is hard to get right now.

Does this affect me? If you need this injection in Austria, you may have trouble getting it.

What should I do? Talk to your pharmacist or doctor before making any changes.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
CANRENOINSÄURE
Agency-published detail

🚫 Parallel export ban active · ATC: C03DA02 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Esteve Pharmaceuticals GmbH, Hohenzollerndamm 150-151, 14199 Berlin, Federal Republic of Germany · Affected packs: 10 Stück Schachtel, Ampulle [eingeschränkt verfügbar, since 2025-04-10, resupply 2026-09-30]

First published
April 10, 2025
Last refreshed by us
3 months ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Aldactone 200 mg/ 10 ml Injektionslösung 200 mg/ 10 ml (Injektionslösung). Parallel export ban in effect. Supply delayed due to manufacturing issues.
▸ When was this alert issued?
This alert was issued on April 10, 2025 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.